Correlation Between Vor Biopharma and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Cue Biopharma, you can compare the effects of market volatilities on Vor Biopharma and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Cue Biopharma.
Diversification Opportunities for Vor Biopharma and Cue Biopharma
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vor and Cue is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Cue Biopharma go up and down completely randomly.
Pair Corralation between Vor Biopharma and Cue Biopharma
Considering the 90-day investment horizon Vor Biopharma is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Vor Biopharma is 1.55 times less risky than Cue Biopharma. The stock trades about -0.05 of its potential returns per unit of risk. The Cue Biopharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 305.00 in Cue Biopharma on September 2, 2024 and sell it today you would lose (183.00) from holding Cue Biopharma or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vor Biopharma vs. Cue Biopharma
Performance |
| Timeline |
| Vor Biopharma |
| Cue Biopharma |
Vor Biopharma and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vor Biopharma and Cue Biopharma
The main advantage of trading using opposite Vor Biopharma and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Vor Biopharma vs. Tff Pharmaceuticals | Vor Biopharma vs. Eliem Therapeutics | Vor Biopharma vs. Inhibrx | Vor Biopharma vs. Enliven Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |